Replies to post #378493 on Anavex Life Sciences Corp (AVXL)

[growingpain]

From the programme, this was their presentation:

"CTAD 2021 Late-Breaking Readout Roundtable Details

Title: Top-line Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer’s Disease"